EBMT 2016

Defibrotide: Redefining the treatment for severe veno-occlusive disease (sVOD) 3:06
Defibrotide: Redefining the treatment for severe veno-occlusive disease (sVOD)
Paul Richardson • 4 Apr 2016
Mohamad Mohty on EBMT 2016 3:01
Mohamad Mohty on EBMT 2016
Mohamad Mohty • 4 Apr 2016
Blinatumomab for treating ALL 1:09
Blinatumomab for treating ALL
Giovanni Martinelli • 3 Apr 2016
Monoclonal antibodies for difficult-to-treat multiple myeloma 2:14
Monoclonal antibodies for difficult-to-treat multiple myeloma
Mohamad Mohty • 4 Apr 2016
Transforming healthcare with Twitter: A physician’s perspective 4:12
Transforming healthcare with Twitter: A physician’s perspective
Navneet Majhail • 4 Apr 2016
Graft-versus-host disease (GvHD): Advances at EBMT 2016 3:12
Graft-versus-host disease (GvHD): Advances at EBMT 2016
Mohamad Mohty • 4 Apr 2016
New monoclonal antibodies for ALL treatment 1:58
New monoclonal antibodies for ALL treatment
Arnon Nagler • 4 Apr 2016
Engaging healthcare professionals and patients with social media 3:28
Engaging healthcare professionals and patients with social media
Michael Thompson • 4 Apr 2016
Change of landscape in CLL treatment 1:53
Change of landscape in CLL treatment
John Gribben • 4 Apr 2016
Strategies to reduce graft-versus-host disease (GvHD) 1:48
Strategies to reduce graft-versus-host disease (GvHD)
Miguel-Angel Perales • 4 Apr 2016
Key questions in the field of CD19 CAR T-cell therapy 4:24
Key questions in the field of CD19 CAR T-cell therapy
Catherine Bollard • 4 Apr 2016
Separation of graft-versus-leukemia from graft-versus-host disease (GvHD) 1:46
Separation of graft-versus-leukemia from graft-versus-host disease (GvHD)
Arnon Nagler • 4 Apr 2016
The changing role of nurses in bone marrow biopsies 2:28
The changing role of nurses in bone marrow biopsies
John Murray • 4 Apr 2016
Overview of Phase III clinical trial UKALL14 for ALL 1:49
Overview of Phase III clinical trial UKALL14 for ALL
David Marks • 4 Apr 2016
Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients 1:04
Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients
Roy Chemaly • 4 Apr 2016
Improving the assessment of response in relapsed MM 1:47
Improving the assessment of response in relapsed MM
Bruno Paiva • 4 Apr 2016
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals